Analysis shows “positive trend” with thinner strut stents in patients with small vessels
Ngày 11/07/2022 08:09 | Lượt xem: 814

A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thinner strut stents in patients with small vessels (<2,5mm) undergoing percutaneous coronary intervention (PCI).

This is according to Eline H Ploumen (Medisch Spectrum Twente, Enschede, The Netherlands), who presented the findings at EuroPCR (17–20 May, Paris, France).

Patients with smaller coronary target vessels are usually associated with a higher risk of target lesion revascularisation (TLR) following percutaneous coronary intervention (PCI). In this context, the BIO-RESORT subgroup analysis aimed to assess whether thinner struts lead to a lower adverse event risk and better patient outcomes.

The randomised trial analysed the five-year outcomes of coronary artery disease patients treated with three contemporary DES of varying strut-thickness—ultrathin (Orsiro), very thin (Synergy) and thin (Resolute Integrity) strut drug-eluting stents.

“Although we have not seen a statistically significant difference in five-year target lesion failure rate, our subgroup-analysis shows a trend towards better outcomes with thinner strut DES for patients with small vessels,” commented Ploumen on the results. “While percutaneous coronary intervention of small vessel lesions remains challenging, thinner strut DES are a good choice for the treatment of these lesions.”

Findings from the study showed that although patients treated with Orsiro DES were more often treated for a complex target lesion than patients with other DES (71.4% for Orsiro vs. 68.7% for Synergy and 63.3% for Resolute Integrity), and the results show favourable outcomes for Biotronik’s ultrathin strut DES, a press release issued by the company noted.

Target lesion failure (TLF) for Orsiro DES remains numerically lower at five years (10.5% for Orsiro vs. 11.1% for Synergy and 12.6% for Resolute Integrity), the study reported, also finding that TLR for Orsiro DES remains numerically lower at five years (4.4% for Orsiro vs. 4.7% for Synergy and 6.8%% for Resolute Integrity). Definite or probable stent thrombosis rate remains numerically lower for Orsiro DES at five years (1.0% for Orsiro vs. 1.7% for Synergy and 2.0% for Resolute Integrity).

The BIO-RESORT non-inferiority study included 3,514 all-comer patients and was designed to assess two biodegradable polymer stents against a durable polymer reference device in all-comers patients. At one-year, non-inferiority was established for Orsiro and Synergy against Resolute Integrity DES3. Last year, full-cohort five-year outcomes from the BIO-RESORT trial were presented at the Transcatheter Cardiovascular Therapeutics conference (TCT 2021; 4–6 November, Orlando, USA and virtual).

Source CardiovascularNews

Duc Tin CLinic

Print Chia sẽ qua facebook bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua google bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua twitter bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua MySpace bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua LinkedIn bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua stumbleupon bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua icio bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua digg bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua yahoo bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua yahoo bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua yahoo bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels Chia sẽ qua yahoo bài: Analysis shows “positive trend” with thinner strut stents in patients with small vessels

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP